Cited by 1,910Acute Kidney Injury ResearchChronic Kidney Disease and DiabetesChemotherapy-induced organ toxicity mitigation

Acute kidney injury

Ronco, Claudio, Bellomo, Rinaldo, Kellum, John A·2019·The Lancet

Abstract

Acute kidney injury (AKI) is defined by a rapid increase in serum creatinine, decrease in urine output, or both. AKI occurs in approximately 10-15% of patients admitted to hospital, while its incidence in intensive care has been reported in more than 50% of patients. Kidney dysfunction or damage can occur over a longer period or follow AKI in a continuum with acute and chronic kidney disease. Biomarkers of kidney injury or stress are new tools for risk assessment and could possibly guide therapy. AKI is not a single disease but rather a loose collection of syndromes as diverse as sepsis, cardiorenal syndrome, and urinary tract obstruction. The approach to a patient with AKI depends on the clinical context and can also vary by resource availability. Although the effectiveness of several widely applied treatments is still controversial, evidence for several interventions, especially when used together, has increased over the past decade.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(19)32563-2

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ronco, C., Bellomo, R., & Kellum, J. A.
Affiliations
  • University of Padua (IT)
  • Austin Hospital (AU)
  • University of Pittsburgh (US)
Corresponding author
Ronco, Claudio
Venue
The Lancet
Publisher
Elsevier BV
Published
2019-11
Volume
394
Issue
10212
Pages
1949-1964
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W4211157472
Cited by
1,910
References
4
Citations by year
2026: 272 · 2025: 365 · 2024: 341 · 2023: 317 · 2022: 278 · 2021: 224 · 2020: 110 · 2019: 1 · 2017: 1
FWCI
23.85
Type
journal article
Language
en
Open access
closed
Locations
The Lancet (publishedVersion)
Funders
Astellas Pharma
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Chemotherapy-induced organ toxicity mitigation
Keywords
acute kidney injury, serum creatinine, urine output, sepsis, cardiorenal syndrome, urinary tract obstruction, kidney injury biomarkers, risk assessment, AKI treatment, chronic kidney disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review